Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3e9d77ff72f5282325b4e142dfa5b4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ea086d48d746b2b216484a396ff6c64 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
1996-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1998-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65491cd9bc4335d002bbc8c6c2591474 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_218a1acccd0032a65f95c7e3f31e898d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c85d0ac0869fe20810243c1f046b67c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b904cd2517c005feb23a1065729dbac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3423053c3303919fef3f77898530721 |
publicationDate |
1998-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5789248-A |
titleOfInvention |
CAPL-specific oligonucleotides and method of inhibiting metastatic cancer |
abstract |
Disclosed are synthetic oligonucleotides having a nucleotide sequence complementary to CAPL nucleic acid. Also disclosed are methods of inhibiting the expression of CAPL gene and methods of inhibiting metastatic cancer using CAPL-specific oligonucleotides. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003134813-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0064437-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6906182-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6680301-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7262177-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003119724-A1 |
priorityDate |
1995-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |